Integrated bioinformatics analyses identify dysregulated miRNAs in lung cancer

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 16, 2014, Pages 2270-2274

  Wang, J ^a   Zhao, Y C ^a   Lu, Y D ^a   Ma, C P ^a  

^a Suzhou Medical College of Soochow University   (China)

Author keywords

Expression; Ingenuity pathway analysis; MiRNA; Target genes

Indexed keywords

GLUTAMATE RECEPTOR; MICRORNA; MICRORNA 126; MICRORNA 140 3P; MICRORNA 182; MICRORNA 183; MICRORNA 18A; MICRORNA 21; MICRORNA 31; MICRORNA 574 5P; MICRORNA 675; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; PROTEIN EXPRESSION; RNA PROCESSING; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE RB1; BIOLOGY; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; LUNG TUMOR; MICROARRAY ANALYSIS;

COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS;

EID: 84927173251     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, MURRAY T, THUN MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. SCOTT WJ, HOWINGTON J, FEIGENBERG S, MOVSAS B, PISTERS K. Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 234S-242S.
3. HENSCHKE CI, YANKELEVITZ DF, MIRTCHEVA R, MCGUINNESS G, MCCAULEY D, MIETTINEN OS. CT screening for lung cancer. AJR Am J Roentgenol 2002; 178: 1053-1057.
4. LEE RC, FEINBAUM RL, AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
5. MALUMBRES M, BARBACID M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003; 3: 459-465.
6. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Ann Rev Med 2009; 60: 167-179.
7. RAMASWAMY S, TAMAYO P, RIFKIN R, MUKHERJEE S, YEANG CH, ANGELO M, LADD C, REICH M, LATULIPPE E, MESIROV JP. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci 2001; 98: 15149.
8. GUO WG, ZHANG Y, GE D, ZHANG YX, LU CL, WANG Q, FAN H. Bioinformatics analyses combined microarray identify the desregulated microRNAs in lung cancer. Eur Rev Med Pharmacol Sci 2013; 17: 1509-1516.
9. IRIZARRY RA, HOBBS B, COLLIN F, BEAZER-BARCLAY YD, ANTONELLIS KJ, SCHERF U, SPEED TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
10. MARAGKAKIS M, ALEXIOU P, PAPADOPOULOS GL, RECZKO M, DALAMAGAS T, GIANNOPOULOS G, GOUMAS G, KOUKIS E, KOURTIS K, SIMOSSIS VA, SETHUPATHY P, VERGOULIS T, KOZIRIS N, SELLIS T, TSANAKAS P, HATZIGEORGIOU AG. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009; 10: 295.
11. JOHN B, ENRIGHT AJ, ARAVIN A, TUSCHL T, SANDER C, MARKS DS. Human MicroRNA targets. PLoS Biol 2004; 2: e363.
12. JEGGARI A, MARKS DS, LARSSON E. miRcode: A map of putative microRNA target sites in the long noncoding transcriptome. Bioinformatics 2012; 28: 2062-2063.
13. LEWIS BP, SHIH IH, JONES-RHOADES MW, BARTEL DP, BURGE CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
14. VERGOULIS T, VLACHOS IS, ALEXIOU P, GEORGAKILAS G, MARAGKAKIS M, RECZKO M, GERANGELOS S, KOZIRIS N, DALAMAGAS T, HATZIGEORGIOU AG. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 2012; 40: D222-D229.
15. ESSELTINE JL, WILLARD MD, WULUR IH, LAJINESS ME, BARBER TD, FERGUSON SS. Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. Mol Pharmacol 2013; 83: 770-780.
16. YAMAGUCHI F, HIRATA Y, AKRAM H, KAMITORI K, DONG Y, SUI L, TOKUDA M. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer 2013; 13: 468.
17. TSANG WP, NG EK, NG SS, JIN H, YU J, SUNG JJ, KWOK TT. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010; 31: 350-358.
18. HERNANDEZ JM, ELAHI A, CLARK CW, WANG J, HUMPHRIES LA, CENTENO B, BLOOM G, FUCHS BC, YEATMAN T, SHIBATA D. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. Ann Surg Oncol 2013; 20(Suppl 3): S625-S635.